Literature DB >> 11490165

Prognosis of Alzheimer's disease: the Rotterdam Study.

A Ruitenberg1, S Kalmijn, M A de Ridder, W K Redekop, F van Harskamp, A Hofman, L J Launer, M M Breteler.   

Abstract

The aim of this study was to construct a prognostic model to predict the progression of Alzheimer's disease (AD). Prevalent and incident cases with AD came from the Rotterdam Study, a population-based prospective cohort study of persons aged 55 years and older, including those living in institutions. Rate of cognitive decline, as measured by the Mini Mental State Examination (MMSE score), was predicted by a random effects model. Risk of institutionalization and death were estimated with polytomous logistic regression analysis. At baseline, 306 subjects were diagnosed with prevalent AD and had complete data on living conditions and cognitive function. After a mean follow-up of 2.1 years, 95 subjects with incident AD had been diagnosed. Prevalent patients showed a slower decline in cognitive function than incident patients (p = 0.004). For prevalent and incident AD patients, high age and low cognitive performance were the strongest predictors for institutionalization and death. These prognostic risk functions can provide information on the decline of Alzheimer patients and might be used to better evaluate the effect of treatments for AD. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11490165     DOI: 10.1159/000054786

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  10 in total

Review 1.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

2.  Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study.

Authors:  JoAnn T Tschanz; Chris D Corcoran; Sarah Schwartz; Katherine Treiber; Robert C Green; Maria C Norton; Michelle M Mielke; Kathleen Piercy; Martin Steinberg; Peter V Rabins; Jeanne-Marie Leoutsakos; Kathleen A Welsh-Bohmer; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

3.  The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration.

Authors:  J Ellul; N Archer; C M L Foy; M Poppe; H Boothby; H Nicholas; R G Brown; S Lovestone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

4.  The association of age with rate of cognitive decline in elderly individuals residing in supporting care facilities.

Authors:  Ramit Ravona-Springer; Xiaodong Luo; James Schmeidler; Michael Wysocki; Gerson T Lesser; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

5.  The Multidimensional Prognostic Index Predicts Mortality in Older Outpatients with Cognitive Decline.

Authors:  Femke C M S Overbeek; Jeannette A Goudzwaard; Judy van Hemmen; Rozemarijn L van Bruchem-Visser; Janne M Papma; Harmke A Polinder-Bos; Francesco U S Mattace-Raso
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

6.  Risks and advantages of detecting individuals unfit to drive: a Markov decision analysis.

Authors:  Sandy Leproust; Emmanuel Lagarde; Louis-Rachid Salmi
Journal:  J Gen Intern Med       Date:  2008-09-09       Impact factor: 5.128

7.  The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.

Authors:  Federica Barocco; Marco Spallazzi; Letizia Concari; Simona Gardini; Annalisa Pelosi; Paolo Caffarra
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Survival time tool to guide care planning in people with dementia.

Authors:  Miriam L Haaksma; Maria Eriksdotter; Debora Rizzuto; Jeannie-Marie S Leoutsakos; Marcel G M Olde Rikkert; René J F Melis; Sara Garcia-Ptacek
Journal:  Neurology       Date:  2019-12-16       Impact factor: 9.910

9.  Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.

Authors:  Massimo Musicco; Katie Palmer; Giovanna Salamone; Federica Lupo; Roberta Perri; Serena Mosti; Gianfranco Spalletta; Fulvia di Iulio; Carla Pettenati; Luca Cravello; Carlo Caltagirone
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

10.  Education plays a greater role than age in cognitive test performance among participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).

Authors:  Valéria Maria de Azeredo Passos; Luana Giatti; Isabela Bensenor; Henning Tiemeier; M Arfan Ikram; Roberta Carvalho de Figueiredo; Dora Chor; Maria Inês Schmidt; Sandhi Maria Barreto
Journal:  BMC Neurol       Date:  2015-10-09       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.